Select therapeutic use:
Indications for MICRhoGAM:
Prevention of Rho(D) sensitization following termination of pregnancies up to 12 weeks gestation.
Each syringe (approx. 50mcg) prevents sensitization to 2.5mL of Rh positive red blood cells.
Rho(D) positive patients.
Single-dose syringes—5, 25